Non-thyroidal illness syndrome predicts poor prognosis in hepatocellular carcinoma patients treated with atezolizumab and bevacizumab.
Saved in:
| Title: | Non-thyroidal illness syndrome predicts poor prognosis in hepatocellular carcinoma patients treated with atezolizumab and bevacizumab. |
|---|---|
| Authors: | Chen IW; Division of Endocrinology and Metabolism, Department of Internal Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.; College of Medicine, Chang Gung University, Taoyuan City, Taiwan., Lin CW; Division of Endocrinology and Metabolism, Department of Internal Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; School of Medicine, National Tsing Hua University, Hsinchu City, Taiwan., Lin PT; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Teng W; College of Medicine, Chang Gung University, Taoyuan City, Taiwan. b101090023@gmail.com.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan. b101090023@gmail.com.; Liver Research Center, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan. b101090023@gmail.com., Su CW; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Wu TH; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of General Surgery, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Hsieh YC; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Chen WT; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Lin CC; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, New Taipei Municipal Tucheng Hospital (Built and Operated By Chang Gung Memorial Hospital), New Taipei City, Taiwan., Lin SM; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Lin CY; College of Medicine, Chang Gung University, Taoyuan City, Taiwan. chunyenlin@gmail.com.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan. chunyenlin@gmail.com. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Jan 27; Vol. 75 (2), pp. 59. Date of Electronic Publication: 2026 Jan 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0851 |
|---|---|
| DOI: | 10.1007/s00262-026-04308-z |
